Serum preadipocyte factor-1 concentrations in females with obesity and type 2 diabetes mellitus: The influence of very low calorie diet, acute hyperinsulinemia, and fenofibrate treatment

Hormone and Metabolic Research

Volumn 45, Issue 11, 2013, Pages 820-826

  Kavalkova, P ^a   Touskova, V ^a   Roubicek, T ^a   Trachta, P ^a   Urbanova, M ^a   Drapalova, J ^a   Haluzikova, D ^a   Mraz, M ^a   Novak, D ^b   Matoulek, M ^a   Lacinova, Z ^a   Haluzik, M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CZECH TECHNICAL UNIVERSITY IN PRAGUE   (Czech Republic)

Author keywords

fenofibrate; insulin resistance; isoglycemic hyper insulinemic clamp; Pref 1; very low calorie diet

Indexed keywords

ADIPONECTIN; FENOFIBRATE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; LEPTIN; PREADIPOCYTE FACTOR 1; PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; LOW CALORY DIET; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ANTHROPOMETRY; BODY WEIGHT; CALORIC RESTRICTION; DIABETES MELLITUS, TYPE 2; FEMALE; FENOFIBRATE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERINSULINISM; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MIDDLE AGED; OBESITY; PPAR ALPHA;

EID: 84885958940     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0033-1353210     Document Type: Article

References (36)

1. Reaven G. M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes: 1988; 37 1595 1607 (Pubitemid 19004941)
2. Mraz M., Lacinova Z., Drapalova J., Haluzikova D., Horinek A., Matoulek M., Trachta P., Kavalkova P., Svacina S., Haluzik M. The effect of very-low-calorie diet on mRNA expression of inflammation-related genes in subcutaneous adipose tissue and peripheral monocytes of obese patients with type 2 diabetes mellitus. J Clin Endocrinol Metab: 2011; 96 E606 E613
3. O'Connell J., Lynch L., Hogan A., Cawood T. J., O'Shea D. Preadipocyte factor-1 is associated with metabolic profile in severe obesity. J Clin Endocrinol Metab: 2011; 96 E680 E684
4. Harp J. B. New insights into inhibitors of adipogenesis. Curr Opin Lipidol: 2004; 15 303 307 (Pubitemid 38716563)
5. Wu Y., Zhou S., Smas C. M. Downregulated expression of the secreted glycoprotein follistatin-like 1 (Fstl1) is a robust hallmark of preadipocyte to adipocyte conversion. Mech Dev: 2010; 127 183 202
6. Jing K., Heo J. Y., Song K. S., Seo K. S., Park J. H., Kim J. S., Jung Y. J., Jo D. Y., Kweon G. R., Yoon W. H., Hwang B. D., Lim K., Park J. I. Expression regulation and function of Pref-1 during adipogenesis of human mesenchymal stem cells (MSCs). Biochim Biophys Acta: 2009; 1791 816 826
7. De Zegher F., Díaz M., Sebastiani G., Martín-Ancel A., Sánchez-Infantes D., López-Bermejo A., Ibáñez L. Abundance of circulating preadipocyte factor 1 in early life. Diabetes Care: 2012; 35 848 849
8. Villena J. A., Kim K. H., Sul H. S. Pref-1 and ADSF/resistin: two secreted factors inhibiting adipose tissue development. Horm Metab Res: 2002; 34 664 670 (Pubitemid 36398704)
9. Mei B., Zhao L., Chen L., Sul H. S. Only the large soluble form of preadipocyte factor-1 (Pref-1), but not the small soluble and membrane forms, inhibits adipocyte differentiation: role of alternative splicing. Biochem J: 2002; 364 137 144 (Pubitemid 34538956)
10. Kim K. A., Kim J. H., Wang Y., Sul H. S. Pref-1 (preadipocyte factor 1) activates the MEK/extracellular signal-regulated kinase pathway to inhibit adipocyte differentiation. Mol Cell Biol: 2007; 27 2294 2308 (Pubitemid 46418483)
11. Sul H. S. Minireview. Pref-1: role in adipogenesis and mesenchymal cell fate. Mol Endocrinol: 2009; 23 1717 1725
12. Gustafson B., Smith U. Cytokines promote Wnt signaling and inflammation and impair the normal differentiation and lipid accumulation in 3T3-L1 preadipocytes. J Biol Chem: 2006; 281 9507 9516 (Pubitemid 43864668)
13. Tseng Y. H., Butte A. J., Kokkotou E., Yechoor V. K., Taniguchi C. M., Kriauciunas K. M., Cypess A. M., Niinobe M., Yoshikawa K., Patti M. E., Kahn C. R. Prediction of preadipocyte differentiation by gene expression reveals role of insulin receptor substrates and necdin. Nat Cell Biol: 2005; 7 601 611 (Pubitemid 40796983)
14. Gong H., Ni Y., Guo X., Fei L., Pan X., Guo M., Chen R. Resistin promotes 3T3-L1 preadipocyte differentiation. Eur J Endocrinol: 2004; 150 885 892 (Pubitemid 38961663)
15. Gustafson B., Smith U. Activation of canonical wingless-type MMTV integration site family (Wnt) signaling in mature adipocytes increases beta-catenin levels and leads to cell dedifferentiation and insulin resistance. J Biol Chem: 2010; 285 14031 14041
16. Diaz Sanchez-Bustamante C., Kelm J. M., Egermann M., Djonov V., Fussenegger M. Ectopic expression of delta FBJ murine osteosarcoma viral oncogene homolog B mediates transdifferentiation of adipose-like spheroids into osteo-like microtissues. Tissue Eng Part A: 2008; 14 1377 1394
17. Nielsen J. H., Svensson C., Galsgaard E. D., Moldrup A., Billestrup N. Beta cell proliferation and growth factors. J Mol Med (Berl): 1999; 77 62 66 (Pubitemid 29146184)
18. Moon Y. S., Smas C. M., Lee K., Villena J. A., Kim K. H., Yun E. J., Sul H. S. Mice lacking paternally expressed Pref-1/Dlk1 display growth retardation and accelerated adiposity. Mol Cell Biol: 2002; 22 5585 5592 (Pubitemid 34755767)
19. Lee K., Villena J. A., Moon Y. S., Kim K. H., Lee S., Kang C., Sul H. S. Inhibition of adipogenesis and development of glucose intolerance by soluble preadipocyte factor-1 (Pref-1). J Clin Invest: 2003; 111 453 461 (Pubitemid 36228002)
20. Villena J. A., Choi C. S., Wang Y., Kim S., Hwang Y. J., Kim Y. B., Cline G., Shulman G. I., Sul H. S. Resistance to high fat diet-induced obesity but exacerbated insulin resistance in mice overexpressing Pref-1: a new model of partial lipodystrophy. Diabetes: 2008; 57 3258 3266
21. Giralt M., Domingo P., Guallar J. P., Rodriguez de la Concepcion M. L., Alegre M., Domingo J. C., Villarroya F. HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV-1/HAART-associated lipodystrophy. Antivir Ther: 2006; 11 729 740 (Pubitemid 44497168)
22. Koutkia P., Grinspoon S. HIV-associated lipodystrophy: pathogenesis, prognosis, treatment, and controversies. Annu Rev Med: 2004; 55 303 317
23. Guerre-Millo M., Gervois P., Raspe E., Madsen L., Poulain P., Derudas B., Herbert J. M., Winegar D. A., Willson T. M., Fruchart J. C., Berge R. K., Staels B. Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity. J Biol Chem: 2000; 275 16638 16642 (Pubitemid 30398891)
24. Cabrero A., Alegret M., Sánchez R. M., Adzet T., Laguna J. C., Vázquez M. Bezafibrate reduces mRNA levels of adipocyte markers and increases fatty acid oxidation in primary culture of adipocytes. Diabetes: 2001; 50 1883 1890 (Pubitemid 33641610)
25. Haluzik M. M., Anderlova K., Dolezalova R., Adamikova A., Haluziková D., Housova J., Svacina S., Haluzik M. Serum adipocyte fatty acid binding protein levels in patients with type 2 diabetes mellitus and obesity: the influence of fenofibrate treatment. Physiol Res: 2009; 58 93 99
26. Anderlova K., Dolezalova R., Housova J., Bosanska L., Haluzikova D., Kremen J., Skrha J., Haluzik M. Influence of PPAR-alpha agonist fenofibrate on insulin sensitivity and selected adipose tissuederived hormones in obese women with type 2 diabetes. Physiol Res: 2007; 56 579 586
27. Matthews D. R., Hosker J. P., Rudenski A. S., Naylor B. A., Treacher D. F., Turner R. C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia: 1985; 28 412 419 (Pubitemid 15018832)
28. Shimomura I., Hammer R. E., Richardson J. A., Ikemoto S., Bashmakov Y., Goldstein J. L., Brown M. S. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev: 1998; 12 3182 3194 (Pubitemid 28496263)
29. Wang M. Y., Grayburn P., Chen S., Ravazzola M., Orci L., Unger R. H. Adipogenic capacity and the susceptibility to type 2 diabetes and metabolic syndrome. Proc Natl Acad Sci USA: 2008; 105 6139 6144 (Pubitemid 351758412)
30. Masella R., Varì R., D'Archivio M., Santangelo C., Scazzocchio B., Maggiorella M. T., Sernicola L., Titti F., Sanchez M., Di Mario U., Leto G., Giovannini C. Oxidised LDL modulate adipogenesis in 3T3-L1 preadipocytes by affecting the balance between cell proliferation and differentiation. FEBS Lett: 2006; 580 2421 2429 (Pubitemid 44389367)
31. Sul H. S., Smas C., Mei B., Zhou L. Function of pref-1 as an inhibitor of adipocyte differentiation. Int J Obes Relat Metab Disord: 2000; 24 04 S15 S19
32. Zhang H., Schulz T. J., Espinoza D. O., Huang T. L., Emanuelli B., Kristiansen K., Tseng Y. H. Cross talk between insulin and bone morphogenetic protein signaling systems in brown adipogenesis. Mol Cell Biol: 2010; 30 4224 4233
33. Yamanouchi K., Yada E., Ishiguro N., Hosoyama T., Nishihara M. Increased adipogenicity of cells from regenerating skeletal muscle. Exp Cell Res: 2006; 312 2701 2711
34. Zhou Y. T., Wang Z. W., Higa M., Newgard C. B., Unger R. H. Reversing adipocyte differentiation: implications for treatment of obesity. Proc Natl Acad Sci USA: 1999; 96 2391 2395 (Pubitemid 29117925)
35. Whitelaw D. C., Smith J. M., Nattrass M. Effects of gemfibrozil on insulin resistance to fat metabolism in subjects with type 2 diabetes and hypertriglyceridaemia. Diabetes Obes Metab: 2002; 4 187 194 (Pubitemid 34567675)
36. Skrha J., Sindelka G., Haas T., Hilgertova J., Justova V. Relation between hypertriacylglycerolemia and the action of insulin in type 2 diabetes mellitus. Cas Lek Cesk: 1994; 133 496 499 (Pubitemid 24270407)